NCT01752699

Methadone in Post-Herpetic Neuralgia Pain

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: University of Sao Paulo · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Neuropathic pain is a common condition and affecting 40 to 70% of the general population. Post-herpetic neuralgia is a condition almost complex and requires a multi modal treatment. Aim: This is a pilot proof-of-principle study designed to evaluate the use of low-dose methadone in post-herpetic neuralgia patients who remained refractory after first and second line treatment for post-herpetic neuralgia (PHN) and had indication for the association of an opioid agent to their current drug regimen.

Conditions

• Post-herpetic Neuralgia

Interventions

Type	Name	Description
DRUG	Methadone	patients with post-herpetic neuralgia take methadone or placebo to treat pain symptoms.
DRUG	Placebo	patients with post-herpetic neuralgia take placebo to treat the pain symptoms.

Timeline

• Start date: 1998-01-01
• Primary completion: 2013-02-01
• Completion: 2013-03-01
• First posted: 2012-12-19
• Last updated: 2013-03-18